You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 10, October 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients

A Controlled Study of Drug Interaction

Guy Chouinard, MD, MSc; Lawrence Annable, BSc; Manuel Serrano, MD; Jean M. Albert, MD; Robert Charette, MD

Arch Gen Psychiatry. 1975;32(10):1295-1307.


Abstract

• In a double-blind, placebo, controlled clinical study, lasting 12 weeks, 48 male and 48 female ambulatory schizophrenic patients were randomly assigned to one of four treatments: placebo; amitriptyline hydrochloride, 125 mg/day; perphenazine, 20 mg/day; or amitriptyline-perphenazine, 20 mg/day. Treatment groups contained an equal number of male and female patients.

Perphenazine alone or in combination was substantially more effective in reducing psychopathological disorder than was the placebo, but there was no evidence to indicate the superiority of the amitriptyline-perphenazine combination over perphenazine alone. Amitriptyline alone was not substantially better than placebo and could not be considered an efficacious medication for the maintenance treatment of these patients. Less response to treatment was made by patients with longer-term records of prior hospitalizations.



Author Affiliations

From the Research Department, Hêpital St-Jean-de-Dieu, Montréal-Gamelin, Québec.


Footnotes

Accepted for publication Dec 18, 1974.

Reprint requests to the Research Department of Research, INRSSANTE, Hêpital St-Jean-de-Dieu, Montréal-Gamelin, Québec, Canada HIN IZO (Dr Chouinard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adjunctive Imipramine in the Treatment of Postpsychotic Depression: A Controlled Trial
Siris et al.
Arch Gen Psychiatry 1987;44:533-539.
ABSTRACT  

Treatment of Secondary Depression in Schizophrenia: A Double-blind, Placebo-Controlled Trial of Amitriptyline Added to Perphenazine
Prusoff et al.
Arch Gen Psychiatry 1979;36:569-575.
ABSTRACT  

Use of Antidepressant Drugs in Schizophrenia
Siris et al.
Arch Gen Psychiatry 1978;35:1368-1377.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.